Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Biocryst Pharma Inc (BCRX)

Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ORLADEYO® (berotralstat) Approved in Colombia GlobeNewswire - Fri Jun 13, 6:00AM CDT

BCRX : 10.37 (-0.29%)
BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries GlobeNewswire - Fri Jun 6, 6:00AM CDT

BCRX : 10.37 (-0.29%)
Best Momentum Stock to Buy for June 4th
Best Momentum Stock to Buy for June 4th Zacks Investment Research - Wed Jun 4, 10:02AM CDT

Here is the stock with buy rank and strong momentum characteristics for investors to consider today, June 4th:BioCryst Pharmaceuticals BCRX: This company which is a leader in the use of crystallography...

BCRX : 10.37 (-0.29%)
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Jun 3, 6:00AM CDT

BCRX : 10.37 (-0.29%)
BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology GlobeNewswire - Mon Jun 2, 6:00AM CDT

BCRX : 10.37 (-0.29%)
BioCryst Highlights Real-world Data Showing ORLADEYO® (berotralstat) Consistently Reduces HAE Attacks Across All Ages GlobeNewswire - Fri May 30, 6:00AM CDT

BCRX : 10.37 (-0.29%)
BioCryst to Present at Upcoming Investor Conferences GlobeNewswire - Tue May 27, 6:00AM CDT

BCRX : 10.37 (-0.29%)
BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat) GlobeNewswire - Fri May 16, 6:00AM CDT

BCRX : 10.37 (-0.29%)
BioCryst Announces FDA Acceptance of NDA for ORLADEYO® (berotralstat) Oral Granules in Patients with Hereditary Angioedema Aged 2 to 11 Years GlobeNewswire - Wed May 14, 6:00AM CDT

BCRX : 10.37 (-0.29%)
Best Momentum Stocks to Buy for May 9th
Best Momentum Stocks to Buy for May 9th Zacks Investment Research - Fri May 9, 10:00AM CDT

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 9th:BioCryst Pharmaceuticals, Inc. BCRX: This biotechnology company has a Zacks Rank #1 and...

WYY : 3.02 (-8.48%)
BCRX : 10.37 (-0.29%)
RMBS : 58.10 (-4.22%)

Barchart Exclusives

Geopolitics, the Fed and Other Can't Miss Items this Week Barchart - 34 minutes ago
The stock market opens a shortened trading week under the shadow of escalating Middle East tensions following Israel's attack on Iran's nuclear, missile and military complex early Friday. Here are 5 things to watch this week in the Market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot